Ohio Startup Opens Orders for At-Home Cognitive Enhancement Device While Advancing Separate Clinical Trials U's ...

A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study. A device that delivers direct stimulation to ...

The at-home brain stimulation device is expected to be available in the second quarter of 2026. The Food and Drug Administration (FDA) has cleared Flow, a prescription home-based cranial ...

The U.S. Food and Drug Administration cleared Flow Neuroscience’s at-home electrical stimulation headset for adults with moderate-to-severe depression A trial of 174 people found the device led to ...

While devices that stimulate the brain invasively have generally been available since 2002, and devices that do so non-invasively have been available since 2013, in recent years, the U.S. Food and ...

HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office ...

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...

The transcranial direct current stimulation (tDCS) technique involves placing electrodes on the patient's skull. The prefrontal montage used in this study (left) represents the electric field ...